Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials

기사 요약

Brian Armstrong-backed NewLimit says it reversed aging in human cells and will begin first clinical trials next year after raising $435M.